Competitive Selection from Single Domain Antibody Libraries Allows Isolation of High-affinity Antihapten Antibodies That Are Not Favored in the Llama Immune Response

Overview

Journal Anal Chem

Specialty Chemistry

Date 2011 Aug 11

PMID 21827167

Citations 38

Authors

Sofia Tabares-da Rosa

Martin Rossotti

Carmen Carleiza

Federico Carrion

Otto Pritsch

Ki Chang Ahn

Jerold A Last

Bruce D Hammock

Gualberto Gonzalez-Sapienza

Affiliations

Soon will be listed here.

Abstract

Single-domain antibodies (sdAbs) found in camelids lack a light chain, and their antigen-binding site sits completely in the heavy-chain variable domain (VHH). Their simplicity, thermostability, and ease in expression have made VHHs highly attractive. Although this has been successfully exploited for macromolecular antigens, their application to the detection of small molecules is still limited to a very few reports, mostly describing low-affinity VHHs. Using triclocarban (TCC) as a model hapten, we found that conventional antibodies, IgG1 fraction, reacted with free TCC with a higher relative affinity (IC(50) 51.0 ng/mL) than did the sdAbs (IgG2 and IgG3, 497 and 370 ng/mL, respectively). A VHH library was prepared, and by elution of phage with limiting concentrations of TCC and competitive selection of binders, we were able to isolate high-affinity clones, K(D) 0.98-1.37 nM (SPR), which allowed development of a competitive assay for TCC with an IC(50) = 3.5 ng/mL (11 nM). This represents a 100-fold improvement with regard to the performance of the sdAb serum fraction, and it is 100-fold better than the IC(50) attained with other antihapten VHHs reported thus far. Despite the modest overall antihapten sdAbs response in llamas, a small subpopulation of high-affinity VHHs is generated that can be isolated by careful design of the selection process.

Citing Articles

TEMPRO: nanobody melting temperature estimation model using protein embeddings.

Alvarez J, Dean S Sci Rep. 2024; 14(1):19074.

PMID: 39154093 PMC: 11330463. DOI: 10.1038/s41598-024-70101-6.

Single-Domain Antibodies as Antibody-Drug Conjugates: From Promise to Practice-A Systematic Review.

Medina Perez V, Baselga M, Schuhmacher A Cancers (Basel). 2024; 16(15).

PMID: 39123409 PMC: 11311928. DOI: 10.3390/cancers16152681.

A novel sustainable immunoassay for sensitive detection of atrazine based on the anti-idiotypic nanobody and recombinant full-length antibody.

Zhao J, Li P, Abd El-Aty A, Xu L, Lei X, Gao S Chem Eng J. 2024; 491.

PMID: 38882000 PMC: 11173377. DOI: 10.1016/j.cej.2024.152039.

Designer Small-Molecule Control System Based on Minocycline-Induced Disruption of Protein-Protein Interaction.

Jha R, Kinna A, Hotblack A, Bughda R, Bulek A, Gannon I ACS Chem Biol. 2024; 19(2):308-324.

PMID: 38243811 PMC: 10877577. DOI: 10.1021/acschembio.3c00521.

A highly sensitive nanobody-based immunoassay detecting SARS-CoV-2 nucleocapsid protein using all-recombinant reagents.

Segovia-de Los Santos P, Padula-Roca C, Simon X, Echaides C, Lassabe G, Gonzalez-Sapienza G Front Immunol. 2023; 14:1220477.

PMID: 37497229 PMC: 10367427. DOI: 10.3389/fimmu.2023.1220477.

References

Zhang J, Tanha J, Hirama T, Huan Khieu N, To R, Tong-Sevinc H . Pentamerization of single-domain antibodies from phage libraries: a novel strategy for the rapid generation of high-avidity antibody reagents. J Mol Biol. 2003; 335(1):49-56. DOI: 10.1016/j.jmb.2003.09.034. View

Muyldermans S . Single domain camel antibodies: current status. J Biotechnol. 2001; 74(4):277-302. DOI: 10.1016/s1389-0352(01)00021-6. View

Lorimer I, Beers R, Pegram C, Bigner D, Pastan I . Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: targeting with a single chain antibody variable domain isolated by phage display. Proc Natl Acad Sci U S A. 1996; 93(25):14815-20. PMC: 26219. DOI: 10.1073/pnas.93.25.14815. View

Spinelli S, Tegoni M, Frenken L, van Vliet C, Cambillau C . Lateral recognition of a dye hapten by a llama VHH domain. J Mol Biol. 2001; 311(1):123-9. DOI: 10.1006/jmbi.2001.4856. View

Spinelli S, Frenken L, Hermans P, Verrips T, Brown K, Tegoni M . Camelid heavy-chain variable domains provide efficient combining sites to haptens. Biochemistry. 2000; 39(6):1217-22. DOI: 10.1021/bi991830w. View

Lange I, Daxenberger A, Meyer H . Studies on the antibody response of Lama glama--evaluation of the binding capacity of different IgG subtypes in ELISAs for clenbuterol and BSA. Vet Immunol Immunopathol. 2001; 83(1-2):1-9. DOI: 10.1016/s0165-2427(01)00376-2. View

Sheedy C, Yau K, Hirama T, MacKenzie C, Hall J . Selection, characterization, and CDR shuffling of naive llama single-domain antibodies selected against auxin and their cross-reactivity with auxinic herbicides from four chemical families. J Agric Food Chem. 2009; 54(10):3668-78. DOI: 10.1021/jf060219i. View

Perez J, Renisio J, Prompers J, van Platerink C, Cambillau C, Darbon H . Thermal unfolding of a llama antibody fragment: a two-state reversible process. Biochemistry. 2001; 40(1):74-83. DOI: 10.1021/bi0009082. View

Franco E, Sonneson G, DeLegge T, Hofstetter H, Horn J, Hofstetter O . Production and characterization of a genetically engineered anti-caffeine camelid antibody and its use in immunoaffinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2009; 878(2):177-86. DOI: 10.1016/j.jchromb.2009.06.017. View

10.

Frenken L, van der Linden R, Hermans P, Bos J, Ruuls R, de Geus B . Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae. J Biotechnol. 2000; 78(1):11-21. DOI: 10.1016/s0168-1656(99)00228-x. View

11.

HAMERS-CASTERMAN C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Songa E . Naturally occurring antibodies devoid of light chains. Nature. 1993; 363(6428):446-8. DOI: 10.1038/363446a0. View

12.

van der Linden R, Frenken L, de Geus B, Harmsen M, Ruuls R, Stok W . Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies. Biochim Biophys Acta. 1999; 1431(1):37-46. DOI: 10.1016/s0167-4838(99)00030-8. View

13.

Doyle P, Arbabi-Ghahroudi M, Gaudette N, Furzer G, Savard M, Gleddie S . Cloning, expression, and characterization of a single-domain antibody fragment with affinity for 15-acetyl-deoxynivalenol. Mol Immunol. 2008; 45(14):3703-13. DOI: 10.1016/j.molimm.2008.06.005. View

14.

Harmsen M, Ruuls R, Nijman I, Niewold T, Frenken L, de Geus B . Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features. Mol Immunol. 2001; 37(10):579-90. DOI: 10.1016/s0161-5890(00)00081-x. View

15.

Anderson G, Goldman E . TNT detection using llama antibodies and a two-step competitive fluid array immunoassay. J Immunol Methods. 2008; 339(1):47-54. DOI: 10.1016/j.jim.2008.08.001. View

16.

Yau K, Groves M, Li S, Sheedy C, Lee H, Tanha J . Selection of hapten-specific single-domain antibodies from a non-immunized llama ribosome display library. J Immunol Methods. 2003; 281(1-2):161-75. DOI: 10.1016/j.jim.2003.07.011. View

17.

Monnet C, Bettsworth F, Stura E, Le Du M, Menez R, Derrien L . Highly specific anti-estradiol antibodies: structural characterisation and binding diversity. J Mol Biol. 2002; 315(4):699-712. DOI: 10.1006/jmbi.2001.5284. View

18.

Ladenson R, Crimmins D, Landt Y, Ladenson J . Isolation and characterization of a thermally stable recombinant anti-caffeine heavy-chain antibody fragment. Anal Chem. 2006; 78(13):4501-8. DOI: 10.1021/ac058044j. View

19.

Alvarez-Rueda N, Behar G, Ferre V, Pugniere M, Roquet F, Gastinel L . Generation of llama single-domain antibodies against methotrexate, a prototypical hapten. Mol Immunol. 2006; 44(7):1680-90. DOI: 10.1016/j.molimm.2006.08.007. View

20.

Zhang J, MacKenzie R, Durocher Y . Production of chimeric heavy-chain antibodies. Methods Mol Biol. 2009; 525:323-36, xv. DOI: 10.1007/978-1-59745-554-1_17. View